Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Caffeine (200 mg) NCT07022496 · Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine At… | Migraine | À vérifier | Phase 4 | RECRUITING | Caffeine extracted from green tea to abort acute attack of Migraine À vérifier | ClinicalTrials.gov 2026-08-13 14:17:14 | Détail |
| HELP-VM — Healthy Living Partnerships for Veterans With Migraine NCT04373330 · NCT04373330 | Migraine | Traitement symptomatique | Non applicable | WITHDRAWN | This pilot study, modeled upon the successful and empirically validated HE… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:14 | Détail |
| Partial Rebreathing Device NCT05546385 · PAREMA1 — PArtial REbreathing for Migraine With Aura 1 | Migraine | À vérifier | Non applicable | TERMINATED | A prospective, multi-centre, randomized, double-blind, sham-controlled, pa… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:14 | Détail |
| Active drug for chronic migraine treatment. NCT07071506 · New Methods for Evaluating Preventive Migraine Treatment | Migraine | À vérifier | Non applicable | RECRUITING | The study aims to test interactions between drug and placebo-responses in… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Actual device PFO closure NCT04100135 · RELIEF — GORE® CARDIOFORM Septal Occluder Migraine Clinical Study | Migraine | À vérifier | Non applicable | TERMINATED | Multi-center, prospective, randomized, placebo- and sham-controlled study… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| ACU-BRAIN — Brain Connectome for Acupuncture-treated Migraine Patients NCT04157192 · NCT04157192 | Migraine | Traitement symptomatique | Non applicable | COMPLETED | Acupuncture has been a means of treating headaches and migraine since 2002… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| ACUPMIGRAINE — The Impact of Acupuncture on Biomarkers of Brain Injur… NCT07292506 · NCT07292506 | Migraine | Immunomodulation · Traitement symptomatique | Non applicable | ACTIVE_NOT_RECRUITING | Migraine is more than just a headache-it can involve changes in the brain… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Amiloride NCT04063540 · APAM — Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on t… | Migraine | À vérifier | Phase 2 | RECRUITING | Recent data suggest involvement of Acid-Sensing Ion Channel channels in th… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| App-Based Migraine Treatment: The Health enSuite Study NCT06797076 · NCT06797076 | Migraine | Traitement symptomatique | Non applicable | NOT_YET_RECRUITING | Health enSuite is a suite of applications designed by our research team at… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Atogepant 60 mg NCT06414044 · STAR — Italian Real-life obServational Study on the effecTiveness, sAfety and To… | Migraine | À vérifier | À vérifier | ACTIVE_NOT_RECRUITING | This goal of this study is to compare three medications used for migraine… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| BE WELL With Migraine: Brain Education and WELLness With Migraine NCT05987592 · NCT05987592 | Migraine | À vérifier | Non applicable | RECRUITING | The goal of this randomized clinical trial is to evaluate two different no… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Biodegradable occluder NCT06203873 · BioMetal — A Comparison of Biodegradable and Metal Occluders in Patients With PF… | Migraine | Traitement symptomatique | Non applicable | RECRUITING | Migraine is one of the most common chronic neurological disorders, posing… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Calcitonin-gene related peptide (CGRP) NCT07021859 · Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide | Migraine | À vérifier | Non applicable | RECRUITING | Calcitonin gene-related peptide (CGRP) is a key neuropeptide in migraine p… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Clorazepate Dipotassium NCT04726592 · CLORMIG — Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Em… | Migraine | À vérifier | Phase 3 | TERMINATED | The purpose of this study is to evaluate the efficacy of clorazepate in ad… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Exploring the Effect of the Transcendental Meditation® Technique on M… NCT06695156 · NCT06695156 | Migraine | À vérifier | Non applicable | COMPLETED | This research will explore the effect of the Transcendental Meditation® Te… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Levcromakalim NCT04853797 · Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migra… | Migraine | Traitement symptomatique | Non applicable | COMPLETED | This study aims to explore the effect of Ivabradine on Levcromakalim-induc… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Mi-Helper NCT06874361 · CALM3 — Cooling to Alleviate Migraine #3 | Migraine | À vérifier | Non applicable | COMPLETED | This is a prospective, double-blind, sham-controlled, randomized, decentra… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| MTX101 NCT06728553 · Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in A… | Migraine | Traitement symptomatique · Thérapie génique | Phase 2 | COMPLETED | The goal of this clinical trial is to learn if drug MTX101 works to treat… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Nerivio device NCT06023953 · Migraine With and Without Aura Characteristics and Response to Remote Electrical… | Migraine | Traitement symptomatique | À vérifier | COMPLETED | This is a Post-marketing, real-world evidence study investigating the safe… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
| Neuromodulation Wearable Device NCT07642414 · A Comprehensive Digital Care Program for Migraine Management | Migraine | À vérifier | Non applicable | RECRUITING | This study evaluates the clinical effectiveness of the Enso for Migraine p… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:13 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Leukocyte Telomere Length and Cross-Sectional and Longitudinal Variat… MRI · PMID 42444504 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Telomere length (TL) has emerged as a candidate predictor for biological aging and age-associated conditions, yet its r… | Brain and behavior 2026-07-14 16:03:25 | Source |
| Standardized Acquisition of Fetal Cardiac Cine MRI: A Practical Guide. MRI · PMID 42444472 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Fetal ultrasound is the primary screening modality for routine prenatal examinations, but its effectiveness can be infl… | Circulation. Cardiovascular imaging 2026-07-14 16:03:25 | Source |
| Advanced on Minimally Invasive Techniques in Facial Rejuvenation: A C… Botulinum toxin type A · PMID 42441192 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Contemporary cosmetic surgical approaches to facial rejuvenation have undergone a significant transformation due to the… | World journal of plastic surgery 2026-07-14 16:03:21 | Source |
| Therapeutic progress in rosacea: targeting the neuro-vascular-immune… Botulinum toxin type A · PMID 42440475 | Migraine | Ralentissement de la progression · Immunomodulation · Traitement symptomatique | Publication | PubMed | Voir la publication source Rosacea is a chronic inflammatory dermatological condition predominantly affecting the facial region. Clinically, rosac… | Frontiers in immunology 2026-07-14 16:03:21 | Source |
| Adenosine-A Regulator of Human Testicular Peritubular Cells. dexamethasone · PMID 42444403 | Migraine | Immunomodulation · Thérapie génique | Publication | PubMed | Voir la publication source Extracellular purines, in particular ATP and adenosine, are regulators of physiological and pathophysiological processe… | Andrology 2026-07-14 16:02:55 | Source |
| Does Anodal Transcranial Direct Current Stimulation Over the Primary… Anodal Transcranial direct current stimulation · PMID 42438490 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Transcranial direct current stimulation (tDCS) has traditionally been assumed to modulate the brain by directly polariz… | Biological psychiatry global open science 2026-07-14 16:01:39 | Source |
| Efficacy and safety of transcranial direct current stimulation in alc… Sham Transcranial direct current stimulation · PMID 42091052 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Current treatment options for alcohol use disorder are limited. Transcranial direct current stimulation has been propos… | Addiction (Abingdon, England) 2026-07-14 16:01:38 | Source |
| Sham tDCS controls: blinding, reliability, and a specification-grade… Sham Transcranial direct current stimulation · PMID 42164710 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Sham transcranial direct current stimulation (tDCS) is essential for causal inference but is commonly implemented as ra… | Frontiers in human neuroscience 2026-07-14 16:01:38 | Source |
| Psilocybin-assisted therapy in treatment-resistant depression: rapid… Psilocybin · PMID 42433813 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Treatment-resistant depression (TRD) remains a major clinical challenge and is typically defined as the persistence of… | Annals of medicine and surgery (2012) 2026-07-12 19:42:55 | Source |
| Psychedelics produce enduring enhancement of reward responsiveness in… Psilocybin · PMID 42432161 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Anhedonia, the blunted responsiveness to previously rewarding stimuli, is a core symptom of several psychiatric disorde… | Neuropsychopharmacology : official publication of the… 2026-07-12 19:42:55 | Source |
| Concurrent effects of EMG-triggered NMES and anodal tDCS on cortical… Anodal Transcranial direct current stimulation · PMID 42431572 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Neuromodulatory interventions are increasingly used to enhance neuroplasticity and motor performance. Electromyography-… | Brain research 2026-07-12 19:40:42 | Source |
| Effects of transcranial electric stimulation on attentional functions… Anodal Transcranial direct current stimulation · PMID 42402271 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Non-invasive brain stimulation techniques, such as transcranial electric stimulation (tES), are increasingly promoted a… | Biological psychology 2026-07-12 19:40:42 | Source |
| Limited Contribution of T Relaxation to GluCEST MRI Signal Difference… MRI · PMID 42423883 | Migraine | À vérifier | Publication | PubMed | Voir la publication source To determine whether measured longitudinal relaxation time (T) differences explain glutamate-weighted CEST (GluCEST) gr… | Molecular imaging and biology 2026-07-10 00:23:20 | Source |
| Outcomes of Neoadjuvant Radiotherapy Followed by Robotic Radical Pros… MRI · PMID 42423939 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Neoadjuvant radiotherapy (RT) in prostate cancer remains investigational. This prospective pilot study evaluated the fe… | Annals of surgical oncology 2026-07-10 00:23:20 | Source |
| Association of AbobotulinumtoxinA and Skinbooster for Periorbital Wri… Botulinum toxin type A · PMID 42420660 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Although multimodal aesthetic treatments are used, the combined effects of botulinum toxin A and hyaluronic acid skinbo… | Aesthetic plastic surgery 2026-07-10 00:23:16 | Source |
| The Efficacy of Laser and Botox Therapies for Post-Thyroidectomy Scar… Botulinum toxin type A · PMID 42420659 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Post-thyroidectomy scars remain a major concern that adversely impacts the patient's quality of life despite surgical a… | Aesthetic plastic surgery 2026-07-10 00:23:16 | Source |
| One-day rejuvenation: a preliminary case series of a multimodal proto… Botulinum toxin type A · PMID 42418230 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Same-day multimodal aesthetic treatments may optimize patient convenience, but concerns remain regarding possible therm… | Journal of cosmetic and laser therapy : official publi… 2026-07-08 20:14:49 | Source |
| CSF galanin and noradrenaline downregulation by psilocybin therapy in… Psilocybin · PMID 42414566 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Psilocybin is a rapid-acting antidepressant, but its mechanism of action in major depressive disorder remains unclear.… | Neuropsychopharmacology : official publication of the… 2026-07-08 12:07:05 | Source |
| α-Adrenergic receptor modulates 5-HT-mediated behavioral effects of M… Psilocybin · PMID 42414551 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Classic serotonergic psychedelics such as psilocybin act as agonists at cortical serotonin (5-HT) 2A receptors (5-HTR),… | Molecular psychiatry 2026-07-08 12:07:05 | Source |
| Geographic Variation in Botulinum Toxin Type A Longevity: A Pilot Com… Botulinum toxin type A · PMID 42403809 | Migraine | À vérifier | Publication | PubMed | Voir la publication source The clinical duration of botulinum toxin type A (BoNT-A) is commonly associated with anatomical factors, yet environmen… | Cureus 2026-07-08 12:06:55 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |